Constipation News and Research

Latest Constipation News and Research

Key signs of appendicitis

A 5-year-old with abdominal pain, nausea and fever may have appendicitis or any of a number of other problems.

3 Aug 2007

NDA for Lubiprostone to treat irritable bowel syndrome with constipation

Sucampo Pharmaceuticals, Inc., has announced that it has submitted a supplemental New Drug Application to the U.S. Food and Drug Administration to seek market approval of a lower strength of lubiprostone (8 mcg) to treat irritable bowel syndrome with constipation (IBS-C).

13 Jul 2007

Polyethylene laxative safe for patients suffering from chronic constipation

A clinical trial including 50 medical centers and 304 patients has confirmed that polyethylene (PEG) laxative is safe for patients suffering from chronic constipation.

23 Jun 2007

Child expert says pureed food for babies is unnecessary and harmful

A leading child care expert in Britain says that feeding babies pureed food is unnecessary and could be harmful to their health.

20 Jun 2007

FDA approves treatment for bacterial vaginosis

Mission Pharmacal has announced that the U.S. Food and Drug Administration (FDA) approved Tindamax (tinidazole) for the treatment of bacterial vaginosis (BV), the most common vaginal infection among women of childbearing age in the United States.

28 May 2007

Lubiprostone may improve symptom relief rates in adults with irritable bowel syndrome with constipation

A new study demonstrated that the active ingredient in AMITIZA (lubiprostone), given 8 mcg twice a day, may improve symptom relief rates in adults with irritable bowel syndrome with constipation (IBS-C).

22 May 2007

Lubiprostone may improve symptom relief rates in adults with irritable bowel syndrome

22 May 2007

Caring for the sick now a public health priority for developing countries

Palliative care is commonly used in developed countries to improve the quality of life of patients with life-threatening illnesses, through strategies aimed mainly at pain relief.

10 May 2007

Traditional African medicines may hold potential for treating high blood pressure

Medicinal plants are an integral part of African culture, one of the oldest and most diverse in the world.

2 May 2007

Neuromed licenses chronic pain product from ALZA Corporation

Neuromed Pharmaceuticals has announced that it has licensed from ALZA Corporation the exclusive U.S. rights to develop and commercialize OROS(R) Hydromorphone, an extended release formulation of a potent opioid analgesic in Phase 3 clinical development.

25 Apr 2007

FDA warns on health risks of potentially contaminated Olives

The U.S. Food and Drug Administration (FDA) is alerting consumers to possible serious health risks from eating olives that may be contaminated with a deadly bacterium, Clostridium botulinum . C. botulinum can cause botulism, a potentially fatal illness.

14 Apr 2007

Biofeedback treatment can successfully re-train bowel muscles

Chronic constipation affects 15 to 20 percent of the U.S. population. Nearly one-third of affected people have dyssynergic defecation, in which muscles used for bowel movements do not work well, but there's some good news.

4 Apr 2007

Common questions about irritable bowel syndrome

Will adding fiber to my diet bring relief? Are dairy products really off limits? Is there a way to actually diagnose what I have, or is it all in my head?

4 Apr 2007

Study results on bifeprunox in patients with schizophrenia

Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals and Lundbeck A/S presented clinical study results on bifeprunox at an international medical congress this week.

2 Apr 2007

FDA announces marketing halt for GI drug, Zelnorm

The Food and Drug Administration (FDA) has requested that Novartis Pharmaceuticals Corporation of East Hanover, New Jersey, voluntarily discontinue marketing of Zelnorm (tegaserod) based on the recently identified finding of an increased risk of serious cardiovascular adverse events (heart problems) associated with use of the drug. Novartis has agreed to voluntarily suspend marketing of the drug in the United States.

30 Mar 2007

Promising new pain-killing drug

A potential new pain-killing drug developed by medical scientists at the University of Leicester and Ferrara in Italy is to be discussed at a public lecture on 20th March.

19 Mar 2007

Overly anxious and driven people susceptible to irritable bowel syndrome

The researchers studied 620 people who had confirmed gastroenteritis caused by a bacterial infection. None had had IBS before, or indeed any serious bowel disorder.

27 Feb 2007

FDA approves antidepressant Cymbalta (duloxetine HCl) for treatment of generalized anxiety disorder

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.

26 Feb 2007

Slow-release morphine helps chronic persistent cough

Slow-release morphine helped a group of patients with long-term, treatment-resistant chronic cough reduce their daily cough score levels by 40 percent.

15 Feb 2007

Antibiotic gives long acting relief to irritable bowel sufferers

Researchers in the U.S. say that a long-acting antibiotic can help treat the symptoms of irritable bowel syndrome (IBS).

19 Oct 2006

Constipation News and Research

Latest Constipation News and Research

Key signs of appendicitis

NDA for Lubiprostone to treat irritable bowel syndrome with constipation

Polyethylene laxative safe for patients suffering from chronic constipation

Child expert says pureed food for babies is unnecessary and harmful

FDA approves treatment for bacterial vaginosis

Lubiprostone may improve symptom relief rates in adults with irritable bowel syndrome with constipation

Lubiprostone may improve symptom relief rates in adults with irritable bowel syndrome

Caring for the sick now a public health priority for developing countries

Traditional African medicines may hold potential for treating high blood pressure

Neuromed licenses chronic pain product from ALZA Corporation

FDA warns on health risks of potentially contaminated Olives

Biofeedback treatment can successfully re-train bowel muscles

Common questions about irritable bowel syndrome

Study results on bifeprunox in patients with schizophrenia

FDA announces marketing halt for GI drug, Zelnorm

Promising new pain-killing drug

Overly anxious and driven people susceptible to irritable bowel syndrome

FDA approves antidepressant Cymbalta (duloxetine HCl) for treatment of generalized anxiety disorder

Slow-release morphine helps chronic persistent cough

Antibiotic gives long acting relief to irritable bowel sufferers

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Constipation News and Research

Latest Constipation News and Research

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in